News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Bayer Biological Products Launches New Global Headquarters, Announces Senior Leadership Team For Division


10/19/2005 5:13:15 PM

BERKELEY, Calif.--(BUSINESS WIRE)--April 8, 2005-- Ceremony at Berkeley Site Heralds Expanded Commitment to Berkeley Area and Global Hemophilia Community Today, Bayer Biological Products (BP) celebrates the new global headquarters for its division, as well as the installment of Bayer BP's new leadership team. This team, who joins Joseph Akers continuing in his role as president of Bayer BP, will be officially announced today in a ceremony at the new Berkeley-based global headquarters. Today's event marks the launch of the new Bayer BP, following the successful divestiture of the division's plasma protein business March 31, 2005. Bayer BP, which manufactures and markets the Kogenate(R) line of products (Kogenate(R) FS/KOGENATE(R) Bayer, Antihemophilic Factor (Recombinant), Formulated with Sucrose) for the treatment of hemophilia A, remains a separate division within Bayer HealthCare.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES